CareDx Receives CE Mark for AlloSeq HCT for Use in Hematopoietic Cell Transplantation
24 mai 2022 06h00 HE
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
CareDx Sponsored ISHLT Innovation Challenge Award Tackles Chronic Lung Allograft Dysfunction
18 mai 2022 07h00 HE
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., May 18, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
In CareDx-Initiated IP Litigation Against Natera, Natera Now Drops 1 of 2 Patents Originally Asserted Against CareDx
17 mai 2022 07h00 HE
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
CareDx Showcases Latest Innovation in Transplantation at European EFI 2022 Conference
11 mai 2022 07h00 HE
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
CareDx Reports First Quarter 2022 Results
05 mai 2022 16h01 HE
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
CareDx Validates Clinical Performance of AlloMap Kidney to Comprehensively Assess Transplant Rejection
05 mai 2022 07h00 HE
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
CareDx Congratulates Board Member Dr. Hannah Valantine on ISHLT Lifetime Achievement Award
28 avr. 2022 10h45 HE
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
CareDx Extends Artificial Intelligence Leadership to Heart Transplantation
28 avr. 2022 07h00 HE
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
CareDx to Report First Quarter 2022 Financial Results
27 avr. 2022 16h01 HE
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...
International Society for Heart and Lung Transplantation Foundation Selects Reg Seeto as Corporate Chair
27 avr. 2022 09h15 HE
|
CareDx, Inc.
SOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically...